Allspring Global Investments Holdings, LLC Veracyte, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 11,065 shares of VCYT stock, worth $373,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,065
Previous 9,325
18.66%
Holding current value
$373,665
Previous $206,000
16.02%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding VCYT
# of Institutions
254Shares Held
82.1MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$263 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$253 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$232 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.81MShares$230 Million1.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.46MShares$117 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.42B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...